Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02044289 · ClinicalTrials.gov registry record
MR Imaging Biomarkers of Disease Response to ECT (Electroconvulsive Therapy) in Depression
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 12
- Enrollment target
NCT02044289 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 12 participants.
The verdict
NCT02044289 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to (a) measure how brain structure, metabolism (how the brain uses energy), and function predict response to electroconvulsive therapy (ECT) for treatment of depression; and (b) measure how ECT changes brain metabolism and function. We will ask you to undergo magnetic resonance imaging (MRI) at three sessions: (1) prior to your first ECT therapy session, (2) after having 4-6 ECT therapy sessions, and (3) approximately two months following your first ECT therapy sessions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02044289
The ClinicalTrials.gov registry entry for NCT02044289 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02044289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02044289 about?
NCT02044289 is a clinical study titled "MR Imaging Biomarkers of Disease Response to ECT (Electroconvulsive Therapy) in Depression". The purpose of this study is to (a) measure how brain structure, metabolism (how the brain uses energy), and function predict response to electroconvulsive therapy (ECT) for treatment of depression; and (b) measure how ECT changes brain metabolism and function. We will ask you to undergo magnetic re...
What is the current status of trial NCT02044289?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2014-06. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT02044289?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.